SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-17-044407
Filing Date
2017-08-21
Accepted
2017-08-21 16:30:41
Documents
2
Period of Report
2017-08-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K v473716_8k.htm 8-K 22303
2 EXHIBIT 99.1 v473716_ex99-1.htm EX-99.1 14903
  Complete submission text file 0001144204-17-044407.txt   38453
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36150 | Film No.: 171043394
SIC: 8731 Services-Commercial Physical & Biological Research